Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,909 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Recruiting

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

NCT07569653

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infections, DNA Virus Infections, +6 more
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Huntington Park, California, United States
  • GSK Investigational Site Sherman Oaks, California, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

NCT06806137

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Salvaleón de Higüey, La Altagracia Province, Dominican Republic
  • GSK Investigational Site Constanza, Dominican Republic
  • GSK Investigational Site Santo Domingo Oeste, Dominican Republic
  • GSK Investigational Site San Pedro Sula, Honduras
View Trial Details
Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

NCT06137118

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
View all 80 locations
View Trial Details

Related conditions